Building reporter virus with recombinant viral proteins for analysis of resistance to antiviral compounds [abstract] by Jung, Eun-gyeong & Burke, Donald H.
Eun-gyeong Jung, Biochemistry  
 
University: Gyeongsang National University  
Year in School: Senior  
Hometown: Busan, South Korea  
Faculty Mentor: Dr. Donald Burke, Molecular Microbiology & Immunology 
Funding Source: Gyeongsang National University 
 
Building reporter virus with recombinant viral proteins for 
analysis of resistance to antiviral compounds  
Eun-gyeong Jung and Donald Burke 
 
In the United States, the Centers for Disease Control and Prevention recently reported 
that the estimated cumulative number of diagnoses of AIDS by Human 
immunodeficiency virus (HIV) was about one million, and half million people were died 
until 2005. This HIV as a retrovirus is composed of two copies of positive single-
stranded (ss)-RNA which codes for the virus’s nine genes enclosed by a conical capsid 
protein (p24). The ss-RNA is tightly bound to nucleocapsid proteins (p7) and several 
enzymes needed for the development of the virion including reverse transcriptase (RT), 
proteases, ribonuclease and integrase. By removing and/or replacing essential coding 
regions, the efficient curative means on HIV infected human beings are highly required. 
Moreover, the creation of the new reporter virus with recombinant RT is needed to allow 
direct comparison of resistance to antiviral compounds. Thus, this study used the 
modified plasmid, pHIV-gpt encoding the HIV-1 provirus HXB2, with the bacterial gpt 
gene for mycophenolic acid resistance substituted for the viral env gene (Page et al., 
1990), which was replaced by a drug selection marker. In our previous study, we 
removed the DNA segment of RT region in pHIV-gpt, called pHIV-gpt-∆RT. Then, a part 
of  pHIV-gpt-∆RT was amplified by using PCR with specific primers. The amplicons 
were digested in the restriction sites, and then this digested fragment will be cloned into 
one of three target plasmids, each of which contains a mutated variant of HIV-1 strain 
NL4-3. The pNL4-3 carries puro-cherry, tomato or GFP in the region of viral nef gene. 
Therefore, we can make a number of reporter viruses through the mechanism of 
recombination, and building the reporter viruses is still on-going work in this project. 
This study should be to help in understanding a gene therapy approach throughout 
direct comparison of resistance to antiviral compounds. 
